Stephanie O'Brien - Director at Apellis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
APLS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Stephanie O'Brien since 08 Jan 2025

Holdings reported by Stephanie O'Brien for Apellis Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 25,666 $606,487 $23.63 01 Jan 2026 Direct
Stock Option (Right to Buy) 14,684 $381,092 $66.30 01 Jan 2026 Direct Common Stock

Transactions reported by Stephanie O'Brien for Apellis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.